Trust and performance management in the medical marketplace.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Long-Acting Lipid-Lowering Injectables and Behavioral Moral Hazard: A Systematic Review of Adherence, Lifestyle Measurement, and Structural Evidence Gaps.Healthcare (Basel, Switzerland) · 2026
   Review
2. Reform of the clinical excellence awards scheme: why are we waiting?Journal of the Royal Society of Medicine · 2012
   Article
3. Do we need more doctors?Journal of the Royal Society of Medicine · 2006
   Article
4. Patient-centred care after Shipman.Journal of the Royal Society of Medicine · 2004
   Article
5. Medical performance management.Journal of the Royal Society of Medicine · 2004
   Article
6. Public trust in health care: the system or the doctor?Quality & safety in health care · 2004
   Article

Corrections and comments

• Commented on by
  Medical performance management.2004

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as